Join
Live feed
·
PRReleasevia Quantisnow
PDS Biotechnology Corporation logo

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

ByQuantisnow·Wall Street's wire, on your screen.
PDSB· PDS Biotechnology Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PDSB (PDS Biotechnology Corporation) and more on Quantisnow.